See more news releases in Biotechnology | Health Care & Hospitals | Medical Pharmaceuticals | Pharmaceuticals

Unilife Analyst and Investor Day Presentation Available on Company's Website

YORK, Pa., March 28, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) announced today that the slide show presentation used at the Company's 2012 Analyst and Investor Day held in New York earlier today is available on its website, http://ir.unilife.com/events.cfm.

About Unilife Corporation

Unilife Corporation (NASDAQ: UNIS / ASX: UNS) is a U.S. based developer and commercial supplier of advanced drug delivery systems. Unilife collaborates with pharmaceutical and biotechnology companies seeking innovative, differentiated devices that can enable or enhance the delivery of injectable drugs and vaccines supplied in either a liquid stable or lyophilized form. The Unifill syringe, the world's first and only prefilled syringe with fully integrated safety features, sits at the leading edge of this diversified portfolio. In addition to prefilled and hypodermic safety syringes with automatic, user-controlled needle retraction, Unilife has other proprietary technology platforms including drug reconstitution delivery systems, auto-injectors, auto-infusion pump systems and specialized devices for targeted organ delivery. Unilife's global headquarters and state-of-the-art manufacturing facilities are located in York, PA. For more information on Unilife, please visit www.unilife.com.

General: UNIS-G

*Investor Contacts (US):*	*Analyst Enquiries*	*Investor Contacts (Australia)*
Todd Fromer / Garth Russell	Lynn Pieper	Jeff Carter
KCSA Strategic Communications	Westwicke Partners	Unilife Corporation
P: + 1 212-896-1215 / 212-896-1250	P: + 1 415-202-5678	P: + 61 2 8346 6500